178 related articles for article (PubMed ID: 27702660)
1. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
3. Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expression.
Tu M; Liu X; Han B; Ge Q; Li Z; Lu Z; Wei J; Song G; Cai B; Lv N; Jiang K; Wang S; Miao Y; Gao W
Mol Med Rep; 2014 Aug; 10(2):663-9. PubMed ID: 24920244
[TBL] [Abstract][Full Text] [Related]
4. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
6. Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.
Tu M; Li H; Lv N; Xi C; Lu Z; Wei J; Chen J; Guo F; Jiang K; Song G; Gao W; Miao Y
Mol Cancer; 2017 Mar; 16(1):66. PubMed ID: 28327155
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
[TBL] [Abstract][Full Text] [Related]
8. Nuclear vasohibin-2 promotes cell proliferation by inducing G0/G1 to S phase progression.
Ge Q; Zhou J; Tu M; Xue X; Li Z; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Miao Y; Gao W
Oncol Rep; 2015 Sep; 34(3):1327-36. PubMed ID: 26177649
[TBL] [Abstract][Full Text] [Related]
9. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.
Li Z; Tu M; Han B; Gu Y; Xue X; Sun J; Ge Q; Miao Y; Qian Z; Gao W
PLoS One; 2014; 9(3):e90358. PubMed ID: 24595063
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of miR-200b/c by inhibiting vasohibin-2 in human retinal microvascular endothelial cells.
Ding Y; Hu Z; Luan J; Lv X; Yuan D; Xie P; Yuan S; Liu Q
Life Sci; 2017 Dec; 191():245-252. PubMed ID: 28882646
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression.
Tee AE; Liu B; Song R; Li J; Pasquier E; Cheung BB; Jiang C; Marshall GM; Haber M; Norris MD; Fletcher JI; Dinger ME; Liu T
Oncotarget; 2016 Feb; 7(8):8663-75. PubMed ID: 26848616
[TBL] [Abstract][Full Text] [Related]
12. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2.
Zhang H; Ye Q; Du Z; Huang M; Zhang M; Tan H
Biomed Pharmacother; 2018 Nov; 107():359-367. PubMed ID: 30099339
[TBL] [Abstract][Full Text] [Related]
13. Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.
Kitahara S; Suzuki Y; Morishima M; Yoshii A; Kikuta S; Shimizu K; Morikawa S; Sato Y; Ezaki T
Mol Cancer; 2014 May; 13():99. PubMed ID: 24885408
[TBL] [Abstract][Full Text] [Related]
14. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a.
Jia P; Cai H; Liu X; Chen J; Ma J; Wang P; Liu Y; Zheng J; Xue Y
Cancer Lett; 2016 Oct; 381(2):359-69. PubMed ID: 27543358
[TBL] [Abstract][Full Text] [Related]
16. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway.
Zhang Y; Xue X; Zhao X; Qin L; Shen Y; Dou H; Sun J; Wang T; Yang DQ
Cancer Med; 2018 Nov; 7(11):5567-5576. PubMed ID: 30318866
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
18. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
20. Vasohibin2 promotes adriamycin resistance of breast cancer cells through regulating ABCG2 via AKT signaling pathway.
Ma D; Wu L; Li S; Sun Z; Wang K
Mol Med Rep; 2017 Dec; 16(6):9729-9734. PubMed ID: 29039601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
